Skip to main content
Nature Communications logoLink to Nature Communications
. 2022 Jul 7;13:3927. doi: 10.1038/s41467-022-30946-9

Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway

Sushil Kumar 1, Ajeya Nandi 1, Snahlata Singh 1, Rohan Regulapati 1, Ning Li 1, John W Tobias 2, Christian W Siebel 3, Mario Andres Blanco 1, Andres J Klein-Szanto 4, Christopher Lengner 1, Alana L Welm 5, Yibin Kang 6, Rumela Chakrabarti 1,
PMCID: PMC9262875  PMID: 35798701

Correction to: Nature Communications 10.1038/s41467-020-20664-5, published online 18 January 2021.

The original version of this Article contained an error in Fig. 7. In Fig. 7a panels “alphaDll1” and “IMD” were inadvertently duplicated. The correct version of Fig. 7a is shown below.graphic file with name 41467_2022_30946_Figa_HTML.jpg

The incorrect version of Fig. 7a is shown below.graphic file with name 41467_2022_30946_Figb_HTML.jpg

The original version of this Article contained an error in the legend of Fig. 7. The sentence “The alone doxorubicin group was used for both the experiments in Fig. 7a–b and 8 d, e (n = 6 Dox, n = 4 αDll1 ab+Dox, n = 4 αDll1 ab+IMD, n = 6 αDll1 ab+Dox+IMD tumors)” was replaced with “The alone doxorubicin and αDll1+Dox groups were used for both the experiments in Fig. 6a–b and 7d,e (n = 6 Dox, n = 4 αDll1 ab+Dox, n = 4 αDll1 ab+IMD, n = 6 αDll1 ab+Dox+IMD tumors)”.

In the original source data file of Fig. 7b, the value for cell 4f contained a wrong number.

These errors been corrected in both the PDF and HTML versions of the Article and the source data has been replaced.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES